Suppr超能文献

一例伴有明显疲劳的与[具体病因未提及]相关的先天性肌无力综合征儿科病例。

A Pediatric Case of -Related Congenital Myasthenic Syndrome with Marked Fatigue.

作者信息

Horibe Takuya, Shimomura Hideki, Tokunaga Sachi, Taniguchi Naoko, Lee Tomoko, Kimura Shigemi, Takeshima Yasuhiro

机构信息

Department of Pediatrics, Hyogo Medical University School of Medicine, Nishinomiya 663-8501, Japan.

Children's Rehabilitation, Sleep and Development Medical Center, Hyogo Prefectural Rehabilitation Central Hospital, Kobe 651-2134, Japan.

出版信息

Children (Basel). 2023 Apr 24;10(5):769. doi: 10.3390/children10050769.

Abstract

Congenital myasthenic syndrome (CMS) is a clinically and genetically heterogeneous inherited disorder that is treatable. Although the disease usually develops at birth or during infancy, some patients develop the disease in the second to third decades of life. Collagen-like tail subunit of asymmetric acetylcholinesterase ()-related CMS is CMS with mutations in the , which results in end-plate acetylcholinesterase deficiency. Diagnostic delay is common in patients with later-onset CMS due to slow progression and fluctuating symptoms. Understanding CMS with atypical and unusual presentations is important to treat this condition effectively. Here, we report a case of -related CMS. A 10-year-old girl presented with only marked fatigue, which was provoked by exercise but improved after 30-60 min of rest. While motor nerve conduction velocity was normal, a compound muscle action potential (CMAP) with four peaks was recorded. Repetitive stimulation of the accessory nerve exhibited a decrease in CMAP amplitude. Genetic tests revealed compound heterozygous mutations in (c.1196-1_1197delinsTG and c.1354C>T). Treatment with salbutamol improved fatigue but not the electrophysiological markers. Thus, significant fatigue is a hallmark of -related CMS; early diagnosis is essential for ensuring appropriate treatment.

摘要

先天性肌无力综合征(CMS)是一种临床和遗传异质性的可治疗遗传性疾病。虽然该病通常在出生时或婴儿期发病,但有些患者在生命的第二个十年到第三个十年发病。与不对称乙酰胆碱酯酶()相关的胶原样尾部亚基的CMS是由于该基因发生突变导致终板乙酰胆碱酯酶缺乏的CMS。由于进展缓慢和症状波动,迟发性CMS患者诊断延迟很常见。了解具有非典型和不寻常表现的CMS对于有效治疗这种疾病很重要。在此,我们报告一例与相关的CMS病例。一名10岁女孩仅表现为明显疲劳,运动可诱发,但休息30 - 60分钟后改善。虽然运动神经传导速度正常,但记录到复合肌肉动作电位(CMAP)有四个波峰。副神经重复刺激显示CMAP波幅降低。基因检测发现该基因存在复合杂合突变(c.1196 - 1_1197delinsTG和c.1354C>T)。沙丁胺醇治疗改善了疲劳,但未改善电生理指标。因此,明显疲劳是与相关的CMS的一个标志;早期诊断对于确保适当治疗至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b92/10217334/52b8ac9f797a/children-10-00769-g001.jpg

相似文献

1
A Pediatric Case of -Related Congenital Myasthenic Syndrome with Marked Fatigue.
Children (Basel). 2023 Apr 24;10(5):769. doi: 10.3390/children10050769.
2
Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Brain. 2008 Mar;131(Pt 3):747-59. doi: 10.1093/brain/awm325. Epub 2008 Jan 7.
3
COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.
Orphanet J Rare Dis. 2024 Mar 12;19(1):113. doi: 10.1186/s13023-024-03116-x.
4
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Mutations.
Curr Neuropharmacol. 2023;21(7):1594-1605. doi: 10.2174/1570159X21666230126145652.
6
COLQ-mutant Congenital Myasthenic Syndrome with Microcephaly: A Unique Case with Literature Review.
Transl Neurosci. 2017 Jul 20;8:65-69. doi: 10.1515/tnsci-2017-0011. eCollection 2017.
8
Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Pediatr Neurol. 2014 Jul;51(1):165-9. doi: 10.1016/j.pediatrneurol.2014.03.012. Epub 2014 Mar 22.
9
[Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Rev Neurol (Paris). 2004 Feb;160(2):163-76. doi: 10.1016/s0035-3787(04)70887-5.

本文引用的文献

2
Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes-A Retrospective Single Centre Cohort Study.
Front Hum Neurosci. 2020 Dec 7;14:560860. doi: 10.3389/fnhum.2020.560860. eCollection 2020.
3
The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.
Curr Opin Neurol. 2019 Oct;32(5):696-703. doi: 10.1097/WCO.0000000000000736.
4
Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
Hum Mol Genet. 2019 Jul 15;28(14):2339-2351. doi: 10.1093/hmg/ddz059.
5
Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome.
Emerg Top Life Sci. 2019 Mar;3(1):19-37. doi: 10.1042/ETLS20180100. Epub 2019 Jan 28.
6
Congenital myasthenic syndromes.
Orphanet J Rare Dis. 2019 Feb 26;14(1):57. doi: 10.1186/s13023-019-1025-5.
7
Congenital myasthenic syndromes in adult neurology clinic: A long road to diagnosis and therapy.
Neurology. 2018 Nov 6;91(19):e1770-e1777. doi: 10.1212/WNL.0000000000006478. Epub 2018 Oct 5.
8
Congenital Myasthenic Syndromes: a Clinical and Treatment Approach.
Curr Treat Options Neurol. 2018 Jul 21;20(9):36. doi: 10.1007/s11940-018-0520-7.
9
The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
Int J Mol Sci. 2018 Jun 5;19(6):1677. doi: 10.3390/ijms19061677.
10
Metabolic myopathies: a practical approach.
Pract Neurol. 2018 Feb;18(1):14-26. doi: 10.1136/practneurol-2017-001708. Epub 2017 Dec 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验